Can You Take Lipitor and Crestor Together?
No, Lipitor (atorvastatin) and Crestor (rosuvastatin) should not be taken together. Both are statins that lower cholesterol by inhibiting HMG-CoA reductase, and combining them increases the risk of serious side effects without added benefit.[1][2]
Why Is Combining Them Risky?
The main concern is rhabdomyolysis, a rare but life-threatening muscle breakdown that can lead to kidney failure. Statins alone cause muscle pain or weakness in 5-10% of users; doubling up amplifies this dose-dependently. Other risks include elevated liver enzymes and severe myopathy.[1][3]
What Do Doctors Recommend Instead?
Physicians rarely prescribe both due to redundant action. Guidelines from the American College of Cardiology advise maximizing one statin first—e.g., high-dose atorvastatin (40-80 mg) or rosuvastatin (20-40 mg)—before adding ezetimibe or PCSK9 inhibitors like Repatha.[2][4] If cholesterol remains uncontrolled, switch statins rather than combine.
When Might It Happen Anyway?
In rare off-label cases, like severe hypercholesterolemia unresponsive to single therapy, low doses might be tried under close monitoring with CK levels and symptoms tracked. But major trials (e.g., STELLAR, EXPLORER) show no superiority over monotherapy.[3]
Crestor vs. Lipitor: Key Differences for Switching
| Feature | Lipitor (Atorvastatin) | Crestor (Rosuvastatin) |
|---------|------------------------|------------------------|
| Potency | Moderate-high | Highest |
| LDL Reduction | 40-60% at max dose | 50-65% at max dose |
| Half-life | 14 hours | 19 hours |
| Generic Cost (30-day, 20-40 mg) | $10-20 | $15-30 |
| Patent Status | Expired 2011 | Expired 2016[5] |
Rosuvastatin edges out on LDL drop but has higher diabetes risk.[2][4]
Common Side Effects and Monitoring
Both cause muscle aches (myalgia), headaches, nausea. Report dark urine or extreme fatigue immediately. Get baseline liver tests and recheck every 6-12 months.[1]
Sources
[1]: FDA Lipitor Label
[2]: FDA Crestor Label
[3]: UpToDate: Statin Combination Therapy
[4]: ACC/AHA Cholesterol Guidelines 2018
[5]: DrugPatentWatch: Crestor Patents